C. Fisser (Regensburg, Germany), M. Patout (Paris, France)
High severity and mortality of non-COVID-19 critically ill patients during the COVID-19 pandemic S. Kim (Ansan, Republic of Korea), J. Sim (Guro, Republic of Korea), W. Jung (Anam, Republic of Korea), Y. Lee (Guro, Republic of Korea), J. Kim (Ansan, Republic of Korea)
| |
Fluid balance as an independent prognostic indicator of in-hospital mortality in heart failure patients with Covid-19 R. Ali (Newark, United States), A. Patel (Newark, United States), N. Mehta (Burlington, United States), J. Slim (Newark, United States), R. Miller (Newark, United States), J. Correia (Newark, United States)
| |
Comparative Study of Clinical Outcomes of Severe and Critical COVID-19 Patients With and Without Hemoperfusion Admitted in a Referral Hospital M. Tibubos (Quezon City, Philippines), R. Royeca (Quezon City, Philippines), P. Evangelista (Quezon City, Philippines), M. Orden (Quezon City, Philippines), G. Ong-Cabrera (Quezon City, Philippines), A. Estabillo (Quezon City, Philippines), R. Mora (Quezon City, Philippines)
| |
Dual Oxygenation in Covid-19 - a Retrospective Cohorot Study I. GUR (Haifa, Israel), E. Fuchs (Haifa, Israel)
| |
Comparison of clinical outcomes between COVID-19 vaccinated and unvaccinated patients admitted to a Respiratory Intensive Care Unit. F. Lionello (Padova (PD), Italy), G. Guarnieri (Padova (PD), Italy), B. Molena (Padova (PD), Italy), C. Giraudo (Padova (PD), Italy), G. Arcaro (Padova (PD), Italy), S. Lococo (Padova (PD), Italy), F. Braccioni (Padova (PD), Italy), A. Achille (Padova (PD), Italy), C. Contessa (Padova (PD), Italy), F. Lugato (Padova (PD), Italy), F. Gallan (Padova (PD), Italy), A. Vianello (Padova (PD), Italy)
| |
Organizing pneumonia due to COVID-19: the experience of one year in an intensive care unit J. Duarte dos Santos Oliveira Rodrigues (Lisbon, Portugal), R. Júnior (Lisbon, Portugal), M. Pinto (Lisbon, Portugal), A. Santos (Lisbon, Portugal), R. Gerardo (Lisbon, Portugal), A. Miguel (Lisbon, Portugal), L. Bento (Lisbon, Portugal)
| |
Risk factors for mortality in COPD patients with COVID-19 admitted to Intensive Care Unit L. Fernandez Barat (Barcelona, Spain), S. Alvarez-Napagao (Barcelona, Spain), M. Barroso (Barcelona, Spain), A. Motos (Barcelona, Spain), A. Gabarrús (Barcelona, Spain), A. Ceccato (Barcelona, Spain), R. Pérez (Barcelona, Spain), D. García (Barcelona, Spain), D. Battaglini (Barcelona, Spain), A. Palomeque (Barcelona, Spain), J. Bermejo (Valladolid, Spain), F. Barbé (Lleida, Spain), A. Torres (Barcelona, Spain)
| |
Urea/albumin ratio associated with mortality in hospitalized COVID-19 patients: a cohort study R. Prudente (Botucatu (SP), Brazil), E. Franco (Botucatu (SP), Brazil), L. Machado (Botucatu (SP), Brazil), L. Brizola (Botucatu (SP), Brazil), M. Santos (Botucatu (SP), Brazil), E. Savadkouhi (Botucatu (SP), Brazil), C. Colombo (Botucatu (SP), Brazil), L. Ishimoto (Botucatu (SP), Brazil), S. Tanni (Botucatu (SP), Brazil)
| |
Is acute phase severity predictive of long-covid-19 development? A. Aceranti (Milan, Italy), S. Vernocchi (Milan, Italy)
| |
Mallampati score is an independent predictor of active oxygen therapy in patients with COVID-19. A. Oraczewska (Katowice, Poland), M. Dyrbus (Katowice, Poland), S. Szmigiel (Katowice, Poland), S. Gaweda (Katowice, Poland), P. Kluszczyk (Katowice, Poland), T. Darocha (Katowice, Poland), T. Cyzowski (Katowice, Poland), E. Trejnowska (Katowice, Poland), A. Swinarew (Katowice, Poland), M. Wita (Katowice, Poland), P. Dubik (Katowice, Poland), S. Kwiatek (Katowice, Poland), M. Jedrzejek (Katowice, Poland), M. Kozlowski (Katowice, Poland), B. Puzanowska (Katowice, Poland), A. Barczyk (Katowice, Poland), S. Skoczynski (Katowice, Poland)
| |
Clinical Characteristics of COVID-19 between ICU and non-ICU patients T. Tuan Kob (SUNGAI BULOH, Malaysia), M. Ibrahim (Hospital UiTM, Puncak Alam, Malaysia), A. Khairuddin (SUNGAI BULOH, Malaysia), M. Mohd Razali (SUNGAI BULOH, Malaysia), R. Abd Razak (SUNGAI BULOH, Malaysia), Z. Abd Aziz (SUNGAI BULOH, Malaysia), N. Hassan (SUNGAI BULOH, Malaysia), M. Ibrahim (Puncak Alam, Malaysia)
| |
4C Mortality Score and high-flow nasal oxygen therapy outcome in COVID-19 P. Pobeha (Košice, Slovakia), I. Paranicova (Košice, Slovakia), S. Bodnarova (Košice, Slovakia), P. Skyba (Košice, Slovakia), P. Jonek (Košice, Slovakia), E. Sokolova (Košice, Slovakia), I. Libakova (Košice, Slovakia), P. Joppa (Košice, Slovakia)
| |
Clinical impact of out-of-ICU non-invasive respiratory support in patients with COVID-19 related pneumonia J. Tarrega Camarasa (Granollers, Spain), I. Castillo Sánchez (Granollers, Spain), J. Bruguet González (Granollers, Spain), Y. Galea Colon (Granollers, Spain), N. Angrill Sellés (Granollers, Spain), E. Barbeta Sánchez (Granollers, Spain)
| |
Air leak in Covid 19: experience from a DGH in the UK A. Aujayeb (Newcastle, United Kingdom)
| |
One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity L. Novelli (Bergamo, Italy), F. Raimondi (Bergamo, Italy), G. Carioli (Bergamo, Italy), A. Carobbio (Bergamo, Italy), S. Pappacena (Bergamo, Italy), L. Malandrino (Bergamo, Italy), R. Biza (Bergamo, Italy), R. Trapasso (Bergamo, Italy), M. Anelli (Bergamo, Italy), M. Amoroso (Bergamo, Italy), C. Allegri (Bergamo, Italy), G. Imeri (Bergamo, Italy), C. Conti (Bergamo, Italy), M. Beretta (Bergamo, Italy), M. Rizzi (Bergamo, Italy), F. Lorini (Bergamo, Italy), M. Senni (Bergamo, Italy), A. Rambaldi (Bergamo, Italy), T. Barbui (Bergamo, Italy), F. Di Marco (Bergamo, Italy)
| |
Amount and distribution of parenchymal abnormalities at CT-scan do not predict awake prone position outcome in Covid-19 F. Raimondi (Bergamo, Italy), S. Pappacena (Bergamo, Italy), L. Novelli (Bergamo, Italy), S. Annibali (Bergamo, Italy), I. Bianco (Bergamo, Italy), L. Malandrino (Bergamo, Italy), S. Cazzaniga (Bergamo, Italy), M. Brivio (Bergamo, Italy), R. Trapasso (Bergamo, Italy), S. Bonetti (Bergamo, Italy), F. Caglioni (Bergamo, Italy), C. Catani (Bergamo, Italy), C. Allegri (Bergamo, Italy), R. Biza (Bergamo, Italy), M. Anelli (Bergamo, Italy), F. Di Marco (Bergamo, Italy)
| |
Noninvasive ventilation(NIV) with auto-titrating EPAP to extubation for Acute Myocardial Infarction(AMI) patient with heart failure M. Tian (Zigong Sichuan, China), Y. Wang (Beijing, China), B. Han (Beijing, China), W. Wang (Beijing, China), Z. Jin (Beijing, China), D. Shen (Beijing, China), G. Wu (Jinan Shan, China)
| |
Assessment of lung recruitment with continuous negative extrathoracic pressure after one-lung ventilation: an experimental investigation Á. Schranc (Geneva, Switzerland), J. Diaper (Geneva, Switzerland), R. Südy (Geneva, Switzerland), F. Peták (Szeged, Hungary), W. Habre (Geneva, Switzerland), G. Albu (Geneva, Switzerland)
| |
Late Breaking Abstract - Awake Prone Positioning for COVID-19 Hypoxemic Respiratory Failure: A Systematic Review and Meta-Analysis of Randomized Trials J. Weatherald (Edmonton, Canada), K. Parhar (Calgary, Canada), Z. Al Duhailib (Riyadh, Saudi Arabia), D. Chu (Hamilton, Canada), A. Granholm (Copenhagen, Denmark), K. Solverson (Calgary, Canada), K. Lewis (Hamilton, Canada), M. Hylander Møller (Copenhagen, Denmark), M. Alshahrani (Dammam, Saudi Arabia), E. Belley-Côté (Hamilton, Canada), N. Loroff (Edmonton, Canada), C. Gatto (Nashville, United States), E. Qian (Nashville, United States), T. Rice (Nashville, United States), D. Niven (Calgary, Canada), H. Stelfox (Calgary, Canada), K. Fiest (Calgary, Canada), D. Cook (Hamilton, Canada), Y. Arabi (Riyadh, Saudi Arabia), W. Alhazzani (Hamilton, Canada)
| |
Late Breaking Abstract - Changes in surface activity of lung surfactant and bronchoalveolar cell profile upon COVID-19-related Acute Respiratory Distress Syndrome C. Autilio (Madrid, Spain), P. Losada-Oliva (Madrid, Spain), D. Sánchez Ortiz (Madrid, Spain), A. Mingote (Madrid, Spain), R. Castejon Diaz (Madrid, Spain), G. Hernandez (Toledo, Spain), G. Díaz (Madrid, Spain), M. Echaide (Madrid, Spain), C. Salas (Madrid, Spain), J. Vargas (Madrid, Spain), J. Perez-Gil (Madrid, Spain)
| |